185 related articles for article (PubMed ID: 9365108)
1. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer.
Arenberg DA; Polverini PJ; Kunkel SL; Shanafelt A; Hesselgesser J; Horuk R; Strieter RM
J Leukoc Biol; 1997 Nov; 62(5):554-62. PubMed ID: 9365108
[TBL] [Abstract][Full Text] [Related]
2. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
[TBL] [Abstract][Full Text] [Related]
3. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer.
Strieter RM; Polverini PJ; Arenberg DA; Walz A; Opdenakker G; Van Damme J; Kunkel SL
J Leukoc Biol; 1995 May; 57(5):752-62. PubMed ID: 7539029
[TBL] [Abstract][Full Text] [Related]
4. Improved survival in tumor-bearing SCID mice treated with interferon-gamma-inducible protein 10 (IP-10/CXCL10).
Arenberg DA; White ES; Burdick MD; Strom SR; Strieter RM
Cancer Immunol Immunother; 2001 Dec; 50(10):533-8. PubMed ID: 11776375
[TBL] [Abstract][Full Text] [Related]
5. Chemokines: angiogenesis and metastases in lung cancer.
Strieter RM; Belperio JA; Phillips RJ; Keane MP
Novartis Found Symp; 2004; 256():173-84; discussion 184-8, 259-69. PubMed ID: 15027490
[TBL] [Abstract][Full Text] [Related]
6. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
[TBL] [Abstract][Full Text] [Related]
7. Cancer CXC chemokine networks and tumour angiogenesis.
Strieter RM; Burdick MD; Mestas J; Gomperts B; Keane MP; Belperio JA
Eur J Cancer; 2006 Apr; 42(6):768-78. PubMed ID: 16510280
[TBL] [Abstract][Full Text] [Related]
8. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.
Keane MP; Belperio JA; Xue YY; Burdick MD; Strieter RM
J Immunol; 2004 Mar; 172(5):2853-60. PubMed ID: 14978086
[TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
White ES; Flaherty KR; Carskadon S; Brant A; Iannettoni MD; Yee J; Orringer MB; Arenberg DA
Clin Cancer Res; 2003 Feb; 9(2):853-60. PubMed ID: 12576459
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
Arenberg DA; Kunkel SL; Polverini PJ; Morris SB; Burdick MD; Glass MC; Taub DT; Iannettoni MD; Whyte RI; Strieter RM
J Exp Med; 1996 Sep; 184(3):981-92. PubMed ID: 9064358
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.
White ES; Strom SR; Wys NL; Arenberg DA
J Immunol; 2001 Jun; 166(12):7549-55. PubMed ID: 11390510
[TBL] [Abstract][Full Text] [Related]
12. CXC chemokines in angiogenesis related to pulmonary fibrosis.
Strieter RM; Belperio JA; Keane MP
Chest; 2002 Dec; 122(6 Suppl):298S-301S. PubMed ID: 12475804
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.
Sun H; Chung WC; Ryu SH; Ju Z; Tran HT; Kim E; Kurie JM; Koo JS
Cancer Prev Res (Phila); 2008 Oct; 1(5):316-28. PubMed ID: 19138976
[TBL] [Abstract][Full Text] [Related]
14. Diversity of the angiogenic phenotype in non-small cell lung cancer.
McClelland MR; Carskadon SL; Zhao L; White ES; Beer DG; Orringer MB; Pickens A; Chang AC; Arenberg DA
Am J Respir Cell Mol Biol; 2007 Mar; 36(3):343-50. PubMed ID: 17079777
[TBL] [Abstract][Full Text] [Related]
15. Out of the shadows: CXC chemokines in promoting aberrant lung cancer angiogenesis.
Strieter RM
Cancer Prev Res (Phila); 2008 Oct; 1(5):305-7. PubMed ID: 19129922
[No Abstract] [Full Text] [Related]
16. Use of Immunodeficient Mice for the Evaluation of CXC Chemokines in the Regulation of Tumor-associated Angiogenesis.
Strieter RM; Addison CL; Ehlert JE; Keane MP; Belperio JA; Burdick MD; Arenberg DA
ILAR J; 1999 Sep; 40(4):175-182. PubMed ID: 11406696
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.
Strieter RM; Belperio JA; Burdick MD; Sharma S; Dubinett SM; Keane MP
Ann N Y Acad Sci; 2004 Dec; 1028():351-60. PubMed ID: 15650260
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokines in angiogenesis relevant to chronic fibroproliferation.
Strieter RM; Belperio JA; Burdick MD; Keane MP
Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):23-6. PubMed ID: 15720231
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
Arenberg DA; Keane MP; DiGiovine B; Kunkel SL; Morris SB; Xue YY; Burdick MD; Glass MC; Iannettoni MD; Strieter RM
J Clin Invest; 1998 Aug; 102(3):465-72. PubMed ID: 9691082
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokines in angiogenesis of cancer.
Strieter RM; Belperio JA; Phillips RJ; Keane MP
Semin Cancer Biol; 2004 Jun; 14(3):195-200. PubMed ID: 15246055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
